Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

Authors

Zhongren Zhou, Washington University School of Medicine in St. Louis
Irina Kalatskaya, Ontario Institute for Cancer Research
Donna Russell, Washington University School of Medicine in St. Louis
Norman Marcon, St. Michael’s Hospital
Maria Cirocco, St. Michael’s Hospital
Paul M. Krzyzanowski, Ontario Institute for Cancer Research
Cathy Streutker, St. Michael’s Hospital
Hua Liang, George Washington University
Virginia R. Litle, Boston University
Tony E. Godfrey, Boston University
Lincoln Stein, Ontario Institute for Cancer Research

Journal

Clinical and Experimental Gastroenterology

Publication Date

2019

Volume

2019

Issue

12

First Page

219

Last Page

229

Document Type

Open Access Publication

DOI

10.2147/CEG.S186958

Rights and Permissions

Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. 2019. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clinical and Experimental Gastroenterology. 2019(12):219-229. https://doi.org/10.2147/CEG.S186958

Recommended Citation

Zhou, Zhongren; Kalatskaya, Irina; Russell, Donna; Marcon, Norman; Cirocco, Maria; Krzyzanowski, Paul M.; Streutker, Cathy; Liang, Hua; Litle, Virginia R.; Godfrey, Tony E.; and Stein, Lincoln, "Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma." Clinical and Experimental Gastroenterology. 2019, 12. 219 - 229. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8021